Replimune (REPL) Debt Ratio (2019 - 2026)
Replimune (REPL) reported Debt Ratio of 0.25 for Q1 2026, up 197.95% on a YoY basis from 0.08 in Q1 2025, and up 75.55% sequentially from 0.14 in Q4 2025.
Replimune (REPL) Debt Ratio (2019 - 2026) Analysis & Trends
Replimune (REPL) has 7 years of Debt Ratio data on file, last reported at 0.25 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio rose 197.95% year-over-year to 0.25; the trailing twelve-month figure through Mar 2026 stood at 0.25 (up 197.95% YoY), and the FY2026 full-year result was 0.25, up 197.95% from the prior year.
- Debt Ratio grew to 0.25 in Q1 2026, from 0.14 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.25 in Q1 2026 to a low of 0.04 in Q4 2022.
- A 5-year average of 0.09 and a median of 0.08 in 2024 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio retreated 8.68% in 2024 and jumped 197.95% in 2026, its largest moves.
- Tracing REPL's Debt Ratio over 5 years: stood at 0.04 in 2022, then jumped by 99.28% to 0.08 in 2023, then retreated by 8.68% to 0.08 in 2024, then surged by 87.52% to 0.14 in 2025, then soared by 75.55% to 0.25 in 2026.
- Business Quant data shows REPL's Debt Ratio at 0.25 in Q1 2026, 0.14 in Q4 2025, and 0.12 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.14 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.10 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.08 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2020 | 0.03 |
| Jun 30, 2020 | 0.03 |
| Mar 31, 2020 | 0.04 |
| Dec 31, 2019 | 0.04 |
| Sep 30, 2019 | 0.06 |